Cardiovascular risk percep- tion and evidence practice gaps in Australian general practice (the AusHEART study). Med J Aust. 2010;192:254 9. S8.1.2-46. Shillinglaw B, Viera AJ, Edwards T, et al. Use of global coronary heart disease risk assessment in practice: a cross-sectional survey of a sample of U.S. physicians. BMC Health Serv Res. 2012;12:20. S8.1.2-47. Game FL, Bartlett WA, Bayly GR, et al. Comparative accuracy of cardiovascular risk prediction methods in patients with diabetes mellitus. Diabetes Obes Metab. 2001;3:279 86. S8.1.2-48. Bastuji-Garin S, Deverly A, Moyse D, et al. The Framingham pre- diction rule is not valid in a European population of treated hyper- tensive patients. J Hypertens. 2002;20:1973 80. S8.1.2-49. Menotti A, Puddu PE, Lanti M. The estimate of cardiovascular risk. Theory, tools and problems. Ann Ital Med Int. 2002;17:81 94. S8.1.2-50. de Visser CL, Bilo HJG, Thomsen TF, et al. Prediction of coronary heart disease: a comparison between the Copenhagen risk score and the Framingham risk score applied to a Dutch population. J Intern Med. 2003;253:553 62. S8.1.2-51. Persson M, Carlberg B, Weinehall L, et al. Risk stratification by guidelines compared with risk assessment by risk equations applied to a MONICA sample. J Hypertens. 2003;21:1089 95. S8.1.2-52. Doust J, Sanders S, Shaw J, et al. Prioritising CVD prevention therapy absolute risk versus individual risk factors. Aust Fam Physician. 2012;41:805 9. S8.1.2-53. Allan GM, Nouri F, Korownyk C, et al. Agreement among cardio- vascular disease risk calculators. Circulation. 2013;127:1948 56. S8.1.2-54. Diverse Populations Collaborative Group. Prediction of mortality from coronary heart disease among diverse populations: is there a common predictive function? Heart. 2002;88:222 8. S8.1.2-55. van den Hoogen PC, Feskens EJ, Nagelkerke NJ, et al. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. 